Winton Group LTD Harrow Health, Inc. Transaction History

Winton Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$8.5 - $12.0 $315,724 - $445,728	-37,144 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$6.99 - $10.6 $10,778 - $16,345	-1,542 Reduced 3.99%	37,144 $338,000
Q2 2021 Aug 10, 2021	BUY	$6.68 - $11.07 $7,555 - $12,520	1,131 Added 3.01%	38,686 $359,000
Q1 2021 Jul 21, 2021	SELL	$6.26 - $11.03 $1,352 - $2,382	-216 Reduced 0.57%	37,555 $253,000
Q4 2020 Feb 12, 2021	SELL	$4.76 - $6.93 $256,997 - $374,157	-53,991 Reduced 58.84%	37,771 $259,000
Q3 2020 Oct 30, 2020	SELL	$4.71 - $7.36 $195,596 - $305,646	-41,528 Reduced 31.16%	91,762 $513,000
Q2 2020 Aug 05, 2020	BUY	$3.61 - $6.47 $180,774 - $323,991	50,076 Added 60.18%	133,290 $694,000
Q1 2020 May 11, 2020	SELL	$3.5 - $7.31 $9,999 - $20,884	-2,857 Reduced 3.32%	83,214 $318,000
Q4 2019 Feb 13, 2020	BUY	$4.6 - $7.88 $132,337 - $226,699	28,769 Added 50.21%	86,071 $670,000
Q3 2019 Nov 08, 2019	BUY	$4.89 - $8.0 $280,206 - $458,416	57,302 New	57,302 $322,000
Q2 2019 Jul 08, 2019	SELL	$4.2 - $8.7 $56,401 - $116,832	-13,429 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$4.75 - $7.1 $63,787 - $95,345	13,429 New	13,429 $67,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.